Stay updated on Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial

Sign up to get notified when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:54:15.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T20:17:13.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-12T01:49:35.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.4.1, replacing Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-04T23:38:55.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Brno-Bohunice (Czechia, 625 00) was added as a study location and Brno - Bohunice was removed. A 'Show glossary' option was added and minor metadata updates were made (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0).
    Difference
    0.1%
    Check dated 2026-01-28T21:20:09.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3, a version update with no substantive changes to the trial details.
    Difference
    0.0%
    Check dated 2026-01-14T04:16:17.000Z thumbnail image

Stay in the know with updates to Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.